NLA ASCVD Risk Assessment Tool 12+

The National Lipid Association

Ontworpen voor iPad

    • Gratis

Schermafbeeldingen

Beschrijving

The National Lipid Association Risk Assessment Tool is based on the NLA’s 2014 Publication: NLA Recommendations for the Patient-Centered Management of Dyslipidemia Part 1. The National Lipid Association released its recommendations, published in the Journal of Clinical Lipidology on September 15, 2014. In the recommendations, the Expert Panel re-affirms the importance of cholesterol goals for the prevention of heart attack and stroke. The recommendations should serve as guidance to clinicians for treating patients with dyslipidemia.

Building on the work of traditional risk calculators, this unique tool offers a step-by-step risk factor elimination process that exposes all the variables used in determining patient risk for Atherosclerotic Cardiovascular Disease. The NLA ASCVD Risk Assessment Tool provides clear, evidence-based support for risk classification, setting appropriate treatment targets and making therapeutic guidance.

While this tool can be downloaded by anyone, this instrument is designed for use by physicians and allied healthcare professionals. This application should be used to supplement, but not replace, the provider’s clinical judgment. Therapeutic options should be individualized and determined between provider and patient. The NLA does not assume any responsibility for any aspect of healthcare administered or not administered with the aid of the information provided within this application.

Nieuw

Versie 1.0.1

This app has been updated by Apple to display the Apple Watch app icon.

Updated web calculator links.

App-privacy

De ontwikkelaar, The National Lipid Association, heeft Apple geen informatie gegeven over de toepassing van het privacybeleid van de app en het beheren van gegevens. Ga voor meer informatie naar het privacybeleid van de ontwikkelaar.

Geen details opgegeven

De ontwikkelaar moet privacydetails opgeven wanneer deze de volgende app-update indient.

Meer van deze ontwikkelaar

NLA 2024 Meetings
Zakelijk
NLA 2022 Scientific Sessions
Productiviteit
NLA 2022 Fall CLU
Productiviteit
NLA 2022 Spring CLU
Productiviteit

Suggesties voor jou

RapidASCVD: ASCVD Risk Calc
Geneeskunde
CV Risk Estimation
Geneeskunde
Hypercholesterolemia
Geneeskunde
Lipid Manager
Geneeskunde
My Heart Risk
Gezondheid en fitness
Cardiology Clinical Questions.
Geneeskunde